Insider Stock Trading History of Boll Andrew R.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Boll Andrew R. since year 2005. The trader's CIK number is 1542150. At the time of this reporting, Boll Andrew R. is the Chief Financial Officer of Imprimis Pharmaceuticals, Inc. . (stock ticker symbol IMMY). See this page for all insider trading activities at Imprimis Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Boll Andrew R. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-01 IMMY Imprimis Pharmaceuticals, Inc. Option Ex 30,000 1.83 54,900
2016-12-19 IMMY Imprimis Pharmaceuticals, Inc. Buy 39,000 1.79 69,810
2016-02-01 IMMY Imprimis Pharmaceuticals, Inc. Option Ex 15,000 3.68 55,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boll Andrew R. (Chief Financial Officer of Imprimis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.